July 31, 2025

NADHJA – Development of a miniaturized measurement system for non-invasive detection of the acute individual metabolic state using artificial intelligence

NADHJA – Development of a miniaturized measurement system for non-invasive detection of the acute individual metabolic state using artificial intelligence

Lactate diagnostics is particularly important in sports medicine performance diagnostics and has been carried out conventionally for almost 100 years using blood samples and laboratory analyses.

This project aims to develop a measurement method and functional model of a mobile device based on the NADHJA analyzer from mfd Diagnostics GmbH, which uses a fluorescence-optical method and artificial intelligence (AI) to non-invasively determine changes in the concentration of the intracellular coenzyme NADH. The aim is to prove that these NADH changes correlate both with the accumulation of lactate at the site of measurement and with the systemic lactate change.

For the first time such a device would revolutionize lactate diagnostics in sports practice and open up the possibility of measuring lactate concentration non-invasively and continuously in real time. Biological waste is completely avoided. The development could also analyze atypical metabolic conditions, such as those that occur in fatigue syndrome, sepsis and long COVID, and thus enable new therapeutic approaches.

We are looking forward to this exciting joint project with the project partners of the Karlsruhe Institute of Technology (KIT), the Institute for Information Processing Technology (ITIV), the Institute for Sport and Sports Science (IfSS) and the Mannheim Institute for intelligent Systems in Medicine (MIISM) of the University Medical Center Mannheim (UMM). We would like to thank the performance diagnostics department of TSG 1899 Hoffenheim for their valuable support.

The project is supported by our location in Mannheim and funded by the state of Baden-Württemberg through the investBW program. We would like to thank the state of Baden-Württemberg for funding this project.

Our latest News

discover more
RHEACELL makes second location in Heidelberg visible

RHEACELL makes second location in Heidelberg visible

Heidelberg, January 28, 2026 – RHEACELL GmbH & Co. KG is continuing to expand its presence in Heidelberg and moved into a second location in the Pfaffengrund district in August last year. At the start of the year, the location is now also becoming visible to the outside world: this week, the company logo will […]

TUM Researchers receive two ERC Grants

TUM Researchers receive two ERC Grants

The European Research Council’s (ERC) Proof of Concept Grants are designed to help researchers turn their findings into real‑world innovations. Two ERC‑funded follow‑up projects at TUM will each receive approximately 150,000 euros in support. The projects focus on virus‑driven cancer treatments and new ways to supply electrons for enzyme‑based technologies. Researchers at TUM have secured […]

Weight Loss in Cancer: Organs Respond to the Disease in a Coordinated Way

Weight Loss in Cancer: Organs Respond to the Disease in a Coordinated Way

Cachexia is a metabolic disorder that causes uncontrolled weight loss and muscle wasting in chronic diseases and cancer. A new study by Helmholtz Munich, in collaboration with the Institute of Physiology of the Czech Academy of Sciences in Prague, Heidelberg University Hospital, the German Center for Diabetes Research (DZD), and the German Center for Cardiovascular […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp